Subject area	Cardiology
More specific subject area	Anticoagulation for atrial fibrillation
Type of data	Table
How data was acquired	Administrative claims data
Data format	Analyzed
Experimental factors	OLDW patients with atrial fibrillation receiving treatment with either warfarin, apixaban, dabigatran, or rivaroxaban
Experimental features	Baseline characteristics (age, gender, and CHADs2 score) and event rates (per 100 person years) for ischemic stroke or systemic embolism and major bleeding.
Data source location	US administrative claims, previously published international clinical trial data
Data accessibility	Individual, patient-level from Optum Labs Data Warehouse is not publically available, but summary data are provided in the tables and in the linked publication [5] (DOI: 10.1016/j.ijcard.2017.07.043). All clinical trial data included have been previously published.